In Vitro Transcription Enzymes Market
完整報告名稱與涵蓋範圍
In Vitro Transcription Enzymes Market Size, Share & Trends Analysis Report, By Enzyme Type (T7 and Engineered RNA Polymerases, DNase I and Nuclease Enzymes, Pyrophosphatase, RNase Inhibitors and Auxiliary Enzymes, Complete IVT Enzyme Mixes), By Grade (Research Grade, GMP Grade), By Application (mRNA Vaccines and Therapeutics, Self-Amplifying and Circular RNA Production, Research and Diagnostic RNA Synthesis), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The in vitro transcription enzymes market covers RNA polymerases, nucleases, pyrophosphatases, RNase inhibitors and complete enzyme mixes used to synthesise messenger, self-amplifying and circular RNA from DNA templates, supplied in research and GMP grades. Capping enzymes and nucleotides are covered in separate InsightAce studies and excluded here.
Enzyme performance governs RNA yield, integrity and impurity profile, so manufacturers are investing in engineered T7 polymerase variants that reduce double-stranded RNA by-products, tolerate modified nucleotides and remain active at higher temperatures, alongside high-purity nucleases and inhibitors free of animal-derived components. GMP-grade supply with full traceability, endotoxin control and regulatory support files has become a differentiator as programs move to commercial scale, and enzyme mixes optimised for specific templates simplify process development. Pandemic-era supply shortages spurred capacity expansion and new entrants, especially in Asia, which has moderated pricing for standard enzymes while premium engineered variants command higher margins.
North America and Europe dominate supply and demand, with China and South Korea expanding domestic GMP enzyme production. Competition involves molecular biology reagent leaders, enzyme engineering specialists, nucleic acid manufacturers with proprietary enzymes and Asian reagent producers.
The InsightAce study supplies US$ forecasts for all enzyme type, grade, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global In Vitro Transcription Enzymes Market Snapshot
Chapter 4. Global In Vitro Transcription Enzymes Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Enzyme Type Estimates & Trend Analysis
5.1. Enzyme Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Enzyme Type:
5.2.1. T7 and Engineered RNA Polymerases
5.2.2. DNase I and Nuclease Enzymes
5.2.3. Pyrophosphatase, RNase Inhibitors and Auxiliary Enzymes
5.2.4. Complete IVT Enzyme Mixes
Chapter 6. Market Segmentation 2: By Grade Estimates & Trend Analysis
6.1. Grade & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
6.2.1. Research Grade
6.2.2. GMP Grade
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. mRNA Vaccines and Therapeutics
7.2.2. Self-Amplifying and Circular RNA Production
7.2.3. Research and Diagnostic RNA Synthesis
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. mRNA Developers and Manufacturers
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. In Vitro Transcription Enzymes Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. New England Biolabs, Inc.
11.2. Thermo Fisher Scientific Inc.
11.3. Roche CustomBiotech
11.4. Aldevron (Danaher)
11.5. TriLink BioTechnologies (Maravai LifeSciences)
11.6. Kactus Bio
11.7. Codexis, Inc.
11.8. Vazyme Biotech Co., Ltd.
11.9. Yeasen Biotechnology (Shanghai) Co., Ltd.
11.10. Takara Bio Inc.
11.11. Promega Corporation
11.12. ArcticZymes Technologies ASA
11.13. Merck KGaA (MilliporeSigma)
11.14. Enzynomics Co., Ltd.
11.15. Qiagen N.V.
圖表清單 List of Tables & Figures
Table 1. Global In Vitro Transcription Enzymes Revenue Forecast by Enzyme Type, 2026-2035 (US$ Mn)
Figure 1. Global In Vitro Transcription Enzymes Market Snapshot, 2026 & 2035
Table 2. Global In Vitro Transcription Enzymes Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 2. Global In Vitro Transcription Enzymes Market Share by Grade, 2026 & 2035
Table 3. Global In Vitro Transcription Enzymes Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. IVT Enzyme Requirements Across mRNA, saRNA and circRNA Manufacturing Processes
Table 4. Global In Vitro Transcription Enzymes Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Engineered Polymerase Innovations Reducing Double-Stranded RNA Impurities
Table 5. North America In Vitro Transcription Enzymes Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific In Vitro Transcription Enzymes Growth Opportunity Analysis
Table 6. Europe In Vitro Transcription Enzymes Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. GMP Enzyme Capacity Expansion and Regional Supply Diversification
Table 7. Asia Pacific In Vitro Transcription Enzymes Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key In Vitro Transcription Enzymes Market Participants
Table 8. Latin America and Middle East & Africa In Vitro Transcription Enzymes Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們